Tectonic Therapeutic Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Public

  • Employees
  • 51

Employees

  • Stock Symbol
  • TECX

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $22.64
  • (As of Friday Closing)

Tectonic Therapeutic General Information

Description

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 490 Arsenal Way
  • Suite 210
  • Watertown, MA 02472
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 490 Arsenal Way
  • Suite 210
  • Watertown, MA 02472
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tectonic Therapeutic Stock Performance

As of 11-Jul-2025, Tectonic Therapeutic’s stock price is $22.64. Its current market cap is $406M with 18.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$22.64 $21.72 $13.70 - $61.07 $406M 18.7M 204K -$3.83

Tectonic Therapeutic Financials Summary

As of 31-Mar-2025, Tectonic Therapeutic has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 192,580 525,021
Revenue 0 0 0 0
EBITDA (63,393) (60,491) (41,774) (31,179)
Net Income (58,667) (57,982) (42,823) (32,180)
Total Assets 314,829 152,905 39,399 47,209
Total Debt 2,632 3,303 4,343 5,792
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tectonic Therapeutic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tectonic Therapeutic‘s full profile, request access.

Request a free trial

Tectonic Therapeutic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and
Drug Discovery
Watertown, MA
51 As of 2024

Ghent, Belgium
 

Melbourne, Australia
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tectonic Therapeutic Competitors (4)

One of Tectonic Therapeutic’s 4 competitors is Confo Therapeutics, a Venture Capital-Backed company based in Ghent, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Confo Therapeutics Venture Capital-Backed Ghent, Belgium
Certa Therapeutics Venture Capital-Backed Melbourne, Australia
Longboard Pharmaceuticals Formerly VC-backed La Jolla, CA
Escient Pharmaceuticals Formerly VC-backed San Diego, CA
To view Tectonic Therapeutic’s complete competitors history, request access »

Tectonic Therapeutic Patents

Tectonic Therapeutic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240409601-A1 Relaxin-2 fusion protein analogs and methods of using same Active 18-May-2023
CA-3237801-A1 Relaxin-2 fusion protein analogs and methods of using same Pending 11-Nov-2021
US-20240325506-A1 Compositions and methods for treatment of gaucher disease Pending 23-Jun-2021
EP-4243855-A1 Compositions and methods for treating pompe disease Pending 16-Nov-2020
EP-4243855-A4 Compositions and methods for treating pompe disease Pending 16-Nov-2020 A61K38/47
To view Tectonic Therapeutic’s complete patent history, request access »

Tectonic Therapeutic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tectonic Therapeutic Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tectonic Therapeutic‘s full profile, request access.

Request a free trial

Tectonic Therapeutic Acquisitions (1)

Tectonic Therapeutic’s most recent deal was a Merger/Acquisition with AVROBIO. The deal was made on 20-Jun-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AVROBIO 20-Jun-2024 Merger/Acquisition Biotechnology
To view Tectonic Therapeutic’s complete acquisitions history, request access »

Tectonic Therapeutic FAQs

  • When was Tectonic Therapeutic founded?

    Tectonic Therapeutic was founded in 2019.

  • Where is Tectonic Therapeutic headquartered?

    Tectonic Therapeutic is headquartered in Watertown, MA.

  • What is the size of Tectonic Therapeutic?

    Tectonic Therapeutic has 51 total employees.

  • What industry is Tectonic Therapeutic in?

    Tectonic Therapeutic’s primary industry is Drug Discovery.

  • Is Tectonic Therapeutic a private or public company?

    Tectonic Therapeutic is a Public company.

  • What is Tectonic Therapeutic’s stock symbol?

    The ticker symbol for Tectonic Therapeutic is TECX.

  • What is the current stock price of Tectonic Therapeutic?

    As of 11-Jul-2025 the stock price of Tectonic Therapeutic is $22.64.

  • What is the current market cap of Tectonic Therapeutic?

    The current market capitalization of Tectonic Therapeutic is $406M.

  • Who are Tectonic Therapeutic’s competitors?

    Confo Therapeutics, Certa Therapeutics, Longboard Pharmaceuticals, and Escient Pharmaceuticals are competitors of Tectonic Therapeutic.

  • What is Tectonic Therapeutic’s annual earnings per share (EPS)?

    Tectonic Therapeutic’s EPS for 12 months was -$3.83.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »